PT-141 (Bremelanotide) is a synthetic peptide that acts on melanocortin receptors in the brain. Research has looked at how it interacts with these central nervous system pathways.
PT-141 (Bremelanotide) is a synthetic peptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) that has been widely studied in laboratory settings for its interaction with melanocortin receptors and associated neuroendocrine signalling pathways. It is supplied exclusively for controlled laboratory and research use and is intended only for qualified scientific investigation.
As part of Retro Wellness’ research compound range, PT-141 is presented with a focus on consistency, quality, and responsible sourcing. Each product is intended strictly for qualified research settings and should only be handled by individuals or organisations with the appropriate facilities, knowledge, and procedures.
Research involving PT-141 has explored its interaction with biological pathways associated with melanocortin receptor activation, central nervous system signalling, neuroendocrine regulation, receptor-mediated communication, and hormonal signalling. It has also been investigated in broader studies examining melanocortin biology, behavioural neuroscience, and molecular mechanisms across a range of experimental models. Ongoing research continues to expand understanding of its biological activity and potential relevance within neuroendocrine, reproductive, and molecular research.
This product is not a medicine, supplement, cosmetic, or food product. It is not intended for human or veterinary use, diagnosis, treatment, prevention, or consumption.
All products available on this site are supplied strictly for laboratory research use only. They are not intended for human or veterinary use, consumption, treatment, diagnosis or therapeutic application. Customers are responsible for ensuring products are handled, stored and used appropriately within a suitable research setting.
